Get started

Pill

ZURA a med tech microcap with catalysts LONGZURA a penny stock has catalysts- an FDA action is soon upcoming and an insider bought a lot more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This pre-revenue company beat earnings with less cash burn than expected. Another earnings report is about a month away. Price has settled to the support of the longest EMA line. I see an opportunity here for a long trade toward the earnings in a month. The longer black RSI line above the 50 level while the shorter green line shows the oversold undervalued condition for an entry.
NASDAQ:ZURALong
by AwesomeAvani
BMY- a large cap pharm loosing market cap SHORTBMY is here on the daily chart. The double top and death cross of the EMA moving averages makes for a strong candidate to short with shares or take put options. A comparsion of the most recent earnings report with the previous one sixty days earlier tells most of the story. The dual time frame RSI indicator shows ongoing wekaness. I will short BMY here and take some call options as well. I am in LLY long in a big position. This will be a race in opposite directions for two large cap pharmaceuticals.
NYSE:BMYShort
by AwesomeAvani
PILL 3x Leverage Medical/ Pharma ETF for swing LONGAMEX:PILL On the 4H Chart, current market price is sitting on the support of order blocks and the EMA200, while in an uptend from a double bottom in the sprint. It is moving into the high volume area of the voluxme profile. For the swing trade, the stop loss is $0.10 below the EMA200 while the targets are marked based on a combination of the horizontal resistances of prior swing pivots along with sell order blocks and the structure of the volume profile. Accordingly, this trade risks $0.60 for about $ 4 to $ 5 of upside making for an excellent swing setup especially since healthcare, medical and pharmacueticals are known to be recession resilient and ETFs are inherently diversified making leveraging a risk probably worth taking.
AMEX:PILLLong
by AwesomeAvani
STRO a biotech startup flips into positive earnings LONGSTRO on a 240 minute chart got trader interest out of earnings that were projected to be net cash outflow into reported actual earnings. This is a remarkable turnaround. The RSI lines surged. The predictive algorithm which relies on a lookback of the regression line for analysis toward the future forecasts a move up much higher. I will take a long trade here seeking 50-60% in a month although the forecast is for a doubling.
NASDAQ:STROLong
by AwesomeAvani
BCAB post earnings is set up LONGBCAB a medical technology penny stock had a good beat on earnings. This means the cash burn was only 70% of what was expected. On the strength of that traders reached. The indicators suggest more upside including RSI lines crossing over the 50 level and the MACD lines bouncing up on the approach to the zero horizontal line. The supply and demand curves crossed. The Luxalgo predictive algorithm doing a pattern lookback analysis has a trend up. I will take a long trade here attempting to get a good piece of the move for realized profit.
NASDAQ:BCABLong
by AwesomeAvani
1
ZYXI reverses from whipsaw volatility LONGXYNI is now ready to reverse long. I analyze this because ZYXI has dropped from overvalued and overbought through the fair value zone into undervalued territory in three trading days by viewing the anchored VWAP bands and the volume profile, The mean VWAP and POC line are confluent at 7.25. This is the logical first target. The MACD lines are negative 4X the amplitude of the the negative histogram on the 2H and impending cross. The mass index is a sensitive signal of reversal potential is about to trigger and probably has done so on lower time frames. I will take ZYXI long with a good entry to be found on a 15-30 minute the time frame when I get an alert that it has crossed over the hand-drawn resistance trend line. I am expecting 8% before the first take profit target and 12% on the overall trade over the next 5 trading days or so. A modest profit for low risk, I think. Anyone in faraway places from the Wall Street market manipulators and FDA, this one is for you.
NASDAQ:ZYXILong
by AwesomeAvani
4
VXRT Vaxart Covid-19, Uptrend and Price TargetVXA-CoV2-1, Vaxart's experimental treatment for Covid-19 is unique in that it's a pill, not an injection. A pill would certainly be easier from a distribution and administration standpoint but also to get higher vaccination rates. On May 3, Vaxart's treatment showed demonstrable CD8 T-cell responses, but didn't produce high levels of neutralizing antibodies in trial participants, which makes it less efficient than traditional COVID-19 injections. On 6/11/2021 Piper Sandler brokerage Initiated Coverage with Overweight rating and a Price Target of $18.00 From a technical analysis point of view, the stock looks in an uptrend.
NASDAQ:VXRTLong
by TopgOptions
NEO LongLooks like we're seeing a trustworthy enough response from NEO after he got shot by the agents. lets hope he still knows kung fu. Gann angles are set u as resistances (didn't use box to reduce clutter), they will serve as the ascending channel's resistance on the uptrend top yellow line is target, bottom yellow line is next buy-in for the skeptics. stop is set at minimum loss, right above that resistance bubble it just bounced off of we're headed for "3" on the 5 point elliot, assuming that first low I based my gann angle off of
Long
by magellanschildren